Expression of MT-ND2 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

MT-ND2 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 3513.71

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

5033.7

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	20919.0
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	18182.5
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	12683.5
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	12646.7
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	11990.9
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	11880.3
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	11477.9
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	11165.6
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	11106.5
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	10512.1
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	10194.6
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	9828.0
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	9244.6
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	9108.5
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	9105.9
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	8987.8
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	8838.5
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	8716.1
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	8422.5
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	8230.7
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	8163.6
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	8126.8
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	7763.4
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	7685.7
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	7531.6
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	7295.9
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	7072.1
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	7044.4
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	6993.5
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	6980.0
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	6959.6
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	6954.0
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	6842.0
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	6549.9
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	6408.1
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	6325.8
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	6247.2
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	6060.1
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	6050.1
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	5987.4
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	5864.0
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	5771.7
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	5769.0
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	5625.3
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	5609.9
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	5586.1
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	5582.4
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	5550.7
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	5544.7
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	5508.0
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	5499.9
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	5491.1
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	5350.8
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	5330.5
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	5306.6
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	5213.7
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	5206.3
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	5130.1
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	5092.3
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	5029.2
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	5025.3
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	4997.2
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	4964.3
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	4864.4
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	4790.9
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	4777.3
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	4772.1
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	4770.8
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	4731.5
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	4537.2
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	4500.3
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	4494.4
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	4421.8
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	4416.0
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	4386.0
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	4216.5
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	4198.0
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	4022.8
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	3980.5
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	3969.4
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	3859.6
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	3691.6
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	3686.8
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	3681.6
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	3675.8
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	3624.8
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	3621.0
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	3525.8
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	3513.7
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	3490.5
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	3482.1
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	3478.4
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	3441.4
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	3387.3
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	3376.3
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	3313.0
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	3305.4
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	3217.3
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	3212.7
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	3196.8
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	2942.3
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	2890.0
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	2888.6
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	2846.5
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	2766.7
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	2694.3
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	2652.2
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	2604.7
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	2571.7
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	2560.1
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	2445.1
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	2413.1
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	2323.5
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	2264.4
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	2221.1
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	2209.7
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	2183.7
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	2180.2
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	2112.2
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	2004.0
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	1997.8
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	1892.8
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	1891.5
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	1861.8
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	1818.6
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	1757.3
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	1694.5
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	1594.9
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	1545.7
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	1316.1
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	1314.4
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	1299.9
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	1109.4
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	1031.3
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	1003.1
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	968.0
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	892.8
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	839.1
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	838.6
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	722.9
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	632.3
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

MT-ND2 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 208.76

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

548.0

Number of samples

Samples

Sample	Description	pTPM
AK005	N, NA, stage:NA, dead, 240 days	2192.5
AK218	N, NA, stage:NA, dead, 180 days	1738.6
AK205	N, NA, stage:NA, dead, 120 days	1658.5
AK015	N, NA, stage:NA, alive, 720 days	1602.2
AK226	N, NA, stage:NA, dead, 360 days	1293.9
AK102	N, NA, stage:NA, alive, 1740 days	1159.3
AK006	N, NA, stage:NA, dead, 360 days	1148.1
AK085	N, NA, stage:NA, alive, 660 days	1118.6
AK134	N, NA, stage:NA, dead, 360 days	1085.9
AK035	N, NA, stage:NA, dead, 210 days	980.7
AK043	N, NA, stage:NA, alive, 660 days	851.4
AK099	N, NA, stage:NA, dead, 420 days	833.6
AK002	N, NA, stage:NA, dead, 570 days	729.8
AK041	N, NA, stage:NA, alive, 810 days	695.9
AK081	N, NA, stage:NA, dead, 180 days	669.3
AK133	N, NA, stage:NA, dead, 360 days	663.3
AK173	N, NA, stage:NA, dead, 180 days	645.3
AK079	N, NA, stage:NA, dead, 210 days	618.4
AK030	N, NA, stage:NA, dead, 120 days	589.2
AK158	N, NA, stage:NA, dead, 360 days	564.8
AK227	N, NA, stage:NA, alive, 300 days	558.5
AK103	N, NA, stage:NA, alive, 1320 days	557.9
AK195	N, NA, stage:NA, dead, 390 days	509.3
AK149	N, NA, stage:NA, dead, 420 days	500.4
AK091	N, NA, stage:NA, dead, 210 days	471.3
AK124	N, NA, stage:NA, alive, 1920 days	436.7
AK167	N, NA, stage:NA, dead, 180 days	404.1
AK123	N, NA, stage:NA, dead, 180 days	372.4
AK066	N, NA, stage:NA, alive, 960 days	368.2
AK089	N, NA, stage:NA, dead, 330 days	359.8
AK072	N, NA, stage:NA, dead, 150 days	357.5
AK213	N, NA, stage:NA, alive, 2010 days	346.5
AK051	N, NA, stage:NA, dead, 360 days	329.5
AK088	N, NA, stage:NA, dead, 360 days	309.1
AK053	N, NA, stage:NA, dead, 300 days	295.6
AK165	N, NA, stage:NA, alive, 360 days	281.4
AK003	N, NA, stage:NA, dead, 600 days	281.0
AK117	N, NA, stage:NA, dead, 210 days	277.7
AK153	N, NA, stage:NA, dead, 240 days	271.3
AK076	N, NA, stage:NA, alive, 660 days	257.5
AK156	N, NA, stage:NA, dead, 330 days	251.0
AK183	N, NA, stage:NA, alive, 360 days	249.4
AK055	N, NA, stage:NA, dead, 240 days	246.3
AK049	N, NA, stage:NA, dead, 180 days	245.8
AK142	N, NA, stage:NA, alive, 90 days	238.3
AK071	N, NA, stage:NA, dead, 540 days	213.3
AK100	N, NA, stage:NA, alive, 960 days	204.3
AK185	N, NA, stage:NA, alive, 330 days	200.8
AK139	N, NA, stage:NA, dead, 270 days	193.6
AK231	N, NA, stage:NA, dead, 240 days	182.6
AK178	N, NA, stage:NA, dead, 240 days	173.2
AK068	N, NA, stage:NA, alive, 360 days	169.7
AK236	N, NA, stage:NA, dead, 360 days	167.8
AK188	N, NA, stage:NA, alive, 420 days	155.4
AK199	N, NA, stage:NA, alive, 1860 days	154.6
AK216	N, NA, stage:NA, dead, 360 days	133.7
AK098	N, NA, stage:NA, dead, 660 days	114.6
AK074	N, NA, stage:NA, alive, 300 days	108.1
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0206330003	Tumor	N/A
CPT0186100003	Tumor	N/A
CPT0123530003	Tumor	N/A
CPT0201710003	Tumor	N/A
CPT0216920008	Tumor	N/A
CPT0218890004	Tumor	N/A
CPT0224390004	Tumor	N/A
CPT0204390003	Normal	N/A
CPT0093590003	Tumor	N/A
CPT0167750004	Tumor	N/A
CPT0204400003	Normal	N/A
CPT0079790003	Tumor	N/A
CPT0218690004	Tumor	N/A
CPT0204370003	Normal	N/A
CPT0161730003	Tumor	N/A
CPT0168720003	Tumor	N/A
CPT0206880003	Tumor	N/A
CPT0189650004	Tumor	N/A
CPT0204350003	Normal	N/A
CPT0168380003	Tumor	N/A
CPT0205890003	Tumor	N/A
CPT0217880003	Tumor	N/A
CPT0206560003	Tumor	N/A
CPT0087680003	Tumor	N/A
CPT0206000004	Tumor	N/A
CPT0218670003	Tumor	N/A
CPT0204340003	Normal	N/A
CPT0189850004	Tumor	N/A
CPT0224330003	Tumor	N/A
CPT0218330004	Tumor	N/A
CPT0167640003	Tumor	N/A
CPT0002410011	Tumor	N/A
CPT0093450003	Tumor	N/A
CPT0206110003	Tumor	N/A
CPT0217430008	Tumor	N/A
CPT0217000004	Tumor	N/A
CPT0196850003	Tumor	N/A
CPT0189250003	Tumor	N/A
CPT0189570004	Tumor	N/A
CPT0162020003	Tumor	N/A
CPT0167530003	Tumor	N/A
CPT0207030003	Tumor	N/A
CPT0127420003	Tumor	N/A
CPT0205670004	Tumor	N/A
CPT0208980003	Tumor	N/A
CPT0206780003	Tumor	N/A
CPT0182500003	Tumor	N/A
CPT0217710008	Tumor	N/A
CPT0168830003	Tumor	N/A
CPT0182550003	Tumor	N/A
CPT0189460003	Tumor	N/A
CPT0167860004	Tumor	N/A
CPT0125220003	Tumor	N/A
CPT0171580008	Tumor	N/A
CPT0087730003	Tumor	N/A
CPT0104330003	Tumor	N/A
CPT0168590003	Tumor	N/A
CPT0205450004	Tumor	N/A
CPT0219080004	Tumor	N/A
CPT0087570003	Tumor	N/A
CPT0162140003	Tumor	N/A
CPT0175060003	Tumor	N/A
CPT0205780003	Tumor	N/A
CPT0218960004	Tumor	N/A
CPT0064650003	Tumor	N/A
CPT0125570003	Tumor	N/A
CPT0190360004	Tumor	N/A
CPT0206670004	Tumor	N/A
CPT0204380003	Normal	N/A
CPT0092440003	Tumor	N/A
CPT0162100003	Tumor	N/A
CPT0221180003	Tumor	N/A
CPT0225760003	Tumor	N/A
CPT0093510003	Tumor	N/A
CPT0190240004	Tumor	N/A
CPT0228220003	Tumor	N/A
CPT0204410003	Normal	N/A
CPT0224540004	Tumor	N/A
CPT0209440003	Tumor	N/A
CPT0089150003	Tumor	N/A
CPT0204360003	Normal	N/A
CPT0168080003	Tumor	N/A
CPT0078580003	Tumor	N/A
CPT0127480003	Tumor	N/A
CPT0204420003	Normal	N/A
CPT0218830004	Tumor	N/A
CPT0225730003	Tumor	N/A
CPT0093360003	Tumor	N/A
CPT0168270003	Tumor	N/A
CPT0206450003	Tumor	N/A
CPT0207090003	Tumor	N/A
CPT0104220003	Tumor	N/A
CPT0224600003	Tumor	N/A
CPT0087950003	Tumor	N/A
CPT0204330003	Normal	N/A
CPT0199770003	Tumor	N/A
CPT0205570003	Tumor	N/A
CPT0093550003	Tumor	N/A
CPT0167970003	Tumor	N/A
CPT0182580003	Tumor	N/A
CPT0168480003	Tumor	N/A
CPT0206230003	Tumor	N/A
CPT0189750004	Tumor	N/A
CPT0217100003	Tumor	N/A
CPT0064890003	Tumor	N/A
CPT0217190003	Tumor	N/A
CPT0218770003	Tumor	N/A
CPT0125510003	Tumor	N/A
CPT0217060003	Tumor	N/A
CPT0071100003	Tumor	N/A
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis